SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-012701
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2074337z10-k.htm 10-K 467516
3 EXHIBIT 10.18 a2074337zex-10_18.htm EX-10.18 19556
4 EXHIBIT 10.35 a2074337zex-10_35.htm EX-10.35 38093
5 EXHIBIT 10.36 a2074337zex-10_36.htm EX-10.36 10232
6 EXHIBIT 23.2 a2074337zex-23_2.htm EX-23.2 2414
7 G917020.JPG g917020.jpg GRAPHIC 4640
  Complete submission text file 0000912057-02-012701.txt   544560
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 02594893
SIC: 2836 Biological Products, (No Diagnostic Substances)